title: The mucosal adjuvanticity of the oligodeoxynucleotides containing a non-methylated CpG motif on BCG and diphtheria toxoid.
abstract: CpG-DNA is currently attracting attention as an effective and safe vaccine adjuvant to prevent from microbial infections. In this report, we examined the effects of oligo B, which is a synthetic CpG-DNA, in mucosal administration of Bacillus Calmette-Guérin (BCG) and diphtheria toxoid (DT). Co-administration with oligo B enhanced BCG-induced delayed type hypersensitivity to purified protein derivative (PPD) in guinea pigs. The titers of anti-DT serum IgG, IgA and mucosal IgA antibodies induced by intranasal administration with DT plus oligo B were significantly higher than that with DT alone. In both C57BL/6 and BALB/c mice, intranasal administration of DT with oligo B induced enough level of antibodies to prevent onset of diphtheria. The analysis of antibody subclasses showed that intranasal administration of oligo B induced not only IgG1 but also IgG2a, IgG2c and IgA anti-DT antibodies. In contrast, there was no or little production of the anti-DT serum IgE. Taken together our data suggest that oligo B is a powerful adjuvant in mucosal immunization.
authors.affiliation: Department of Safety Research on Blood and Biological Products, National Institute of Infectious Diseases, Gakuen, Musashimurayama, Tokyo 208-0011, Japan. meymj@nih.go.jp
authors.forename: Jun-Ichi
authors.initials: J
authors.lastname: Maeyama
authors.forename: Takako
authors.initials: T
authors.lastname: Komiya
authors.forename: Motohide
authors.initials: M
authors.lastname: Takahashi
authors.forename: Masanori
authors.initials: M
authors.lastname: Isaka
authors.forename: Norihisa
authors.initials: N
authors.lastname: Goto
authors.forename: Saburo
authors.initials: S
authors.lastname: Yamamoto
mesh_terms: D000276:Adjuvants, Immunologic / Q000008:administration & dosage / Q000494:pharmacology*; D000281:Administration, Intranasal; D000818:Animals; D000907:Antibodies, Bacterial / Q000032:analysis / Q000097:blood; D016207:Cytokines / Q000378:metabolism; D004168:Diphtheria Toxoid / Q000008:administration & dosage / Q000276:immunology*; D005260:Female; D006168:Guinea Pigs; D018928:Immunity, Mucosal; D007070:Immunoglobulin A / Q000032:analysis / Q000097:blood; D007073:Immunoglobulin E / Q000097:blood; D007074:Immunoglobulin G / Q000097:blood; D007963:Leukocytes, Mononuclear / Q000276:immunology; D051379:Mice; D008807:Mice, Inbred BALB C; D008810:Mice, Inbred C57BL; D009092:Mucous Membrane / Q000276:immunology; D009163:Mycobacterium bovis / Q000276:immunology*; D009838:Oligodeoxyribonucleotides / Q000008:administration & dosage / Q000494:pharmacology*; D013154:Spleen / Q000276:immunology; D014374:Tuberculin Test
chemical_list: D000276:Adjuvants, Immunologic; D000907:Antibodies, Bacterial; C408982:CPG-oligonucleotide; D016207:Cytokines; D004168:Diphtheria Toxoid; D007070:Immunoglobulin A; D007074:Immunoglobulin G; D009838:Oligodeoxyribonucleotides; D007073:Immunoglobulin E